Fruits, Vegetables Could Reduce Multiple Sclerosis Symptoms

Eating a healthy diet rich in fruits, vegetables, and whole grains may be especially important for patients with multiple sclerosis (MS). A new study published by Neurology suggests that patients with MS who eat healthier have less disability and experience fewer symptoms than patients who eat unhealthy.
 
Included in the study were 6989 patients with MS who participated in the North American Research Committee registry. Patients were grouped into 5 cohorts based on the health of their diet. The investigators classified a healthy diet as one that mainly included fruits, vegetables, legumes, and whole grains, while lessening the intake of sugar in desserts, sweetened beverages, and red and processed meats. 
 
The authors also determined how healthy patients were by assessing factors such as weight, physical activity levels, eating habits, and smoking status.
 
Patients were also asked about relapses or worsening of symptoms over the previous 6 months, in addition to reporting disability level and symptom severity, including fatigue, mobility, pain, and depression, according to the authors.
 
The researchers discovered that patients with the healthiest diet were 20% less likely to have severe disability compared with the least healthy patients, according to the study. These findings were confirmed after adjusting for potentially confounding factors, including age and time since diagnosis.
 
Patients who consumed the healthiest diet were also 20% less likely to experience severe depression compared with patients who ate the least healthy diet.
 
The authors found that patients with the best diet ate 1.7 servings of whole grains per day and 3.3 servings per day of fruits, vegetables, and legumes compared with 0.3 servings per day and 1.7 servings per day for with the least healthy diet, respectively, according to the study.
 
Significantly, patients who led an overall healthy lifestyle were 50% less likely to experience depression, 30% less likely to experience fatigue, and 40% less likely to experience pain compared with unhealthy patients, according to the study.
 
The investigators also examined whether following a specific diet or weight loss plan can improve the symptoms MS, such as the Paleo diet and the Wahls’ diet. The authors found that the use of these diets may result in a modestly reduced risk of disability progression.
 
While this study suggests that a healthy diet and lifestyle can improve MS disease progression, the authors caution that it cannot be known whether a healthy diet can predict symptoms into the future.
 
“People with MS often ask if there is anything they can do to delay or avoid disability, and many people want to know if their diet can play a role, but there have been few studies investigating this,” said study author Kathryn C. Fitzgerald, ScD. “While this study does not determine whether a healthy lifestyle reduces MS symptoms or whether having severe symptoms makes it harder for people to engage in a healthy lifestyle, it provides evidence for the link between the two.” 


Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Most Popular

Related Articles

Stopping treatment with fingolimod (Gilenya) can cause the disease to become much worse than before the medicine was started or while it was being taken, FDA officials warned
New study finds that ocrelizumab (Ocrevus) has the capability to reduce risk of upper extremity disability progression in patients with primary progressive multiple sclerosis (PPMS).
The FDA has expanded the approved use of Seattle Genetics’ Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$